Commentary

Musings Of A Blind Man-Reflections On The Health Care Industry by Robert Patricelli
Never has the parable of the three blind men feeling the elephant been more apt than in the case of the American health care industry and its participants today. The pace of change is simply breathtaking to all of us in the trenches who are watching it happen to us and trying to discern its future directions. Not a week goes by that we do not read of some new business combination, acquisition, or product development. We have indeed been like the three blind men-representing in this case the insurance, provider, and health maintenance organization (HMO) sectors-all feeling a fast moving elephant in the hope of determining what it is and where it's going. What follows are the musings of one blind man-albeit one with a foot in at least two of the sectors, the insurance and HMO businesses-as to what is happening.
A Remarkable Consensus
Perhaps never before in our national history has a major industry-the third largest contributor to GNP-reorganized so substantially in the space of less than ten years. It is the economic equivalent of an ocean liner turning on a dime. Yet in the midst of all this change, a strategic consensus is emerging among the major competitors on the likely shape of health care delivery in the future. The future is called "managed care" -a term that is meant to encompass HMOs, preferred provider organizations (PPOs), fee-for-service medicine subject to third-party utilization review, and any hybrids among these products. The future is not old-style fee-for-service medicine and indemnity insurance. Whereas "unmanaged fee-for-service" constituted about 95 percent of health care delivery in 1980, many are now predicting that the pattern will flip-flop in the 1990s with managed care constituting 95 percent of the business.
Further, within this consensus on managed care is emerging a corollary-that the employee benefit product of the future is what has come to be called the triple option. This is a package which offers an employee a choice of an HMO, PPO, or indemnity option, and which is sold to the employer bundled together under single administration and probably all experience rated. This is a powerful product. It gives the employee the ability to make his or her own choice along the continuum of trade-offs between price and freedom of choice. For the employer, it responds to his growing conviction that HMOs are pocketing utilization savings that he should share, and it helps to reduce his administrative burdens. Over time, it seems likely that. the triple option will mutate into a variety of forms offering more or less than three choices and ultimately fitting into the broader trend toward flexible benefits. But the basic concept of integrated prepaid and indemnity products operating within an experience-rated framework seems likely to prevail.
If the good news for industry participants is that these future directions are emerging more clearly, the bad news is that it is hard to get there from where they are. Insurers traditionally lack the provider management skills to manufacture the managed care triple choice product. Hospitals and physicians arguably have some provider management skills but lack marketing networks and the ability to manufacture insurance products. In addition, HMOs are discovering that they need to get into the indemnity business to produce integrated products and that they usually lack good broker marketing channels.
So the parties are all scrambling to make up for their shortcomings. This is producing the "joint venture or merger-of-the-week" phenomenon. From their different starting points, the insurance, hospital chain, and HMO companies are all fighting to position themselves for managed care and triple choice products through either vertical integration or joint venture approaches.
Six Paths To A Common Strategy
Amid the confusion, six basic patterns seem to be emerging as the competitors struggle toward this strategic objective.
(1) Insurer-initiated vertical integration. This approach is being taken by four of the eight carriers (including Blue Cross/ Blue Shield) who comprise approximately two-thirds of the, group insurance marketplace. CIGNA, with nineteen HMOs and over 860,000 members, the Prudential with seventeen HMOs and over 445,000 members, the Travelers with its newly acquired Whittaker chain of start-up plans, and the Blues with over seventy-five plans and 2.5 million members, are all seeking to manufacture and distribute integrated prepaid and indemnity products through their own resources.
(2) Hospital-initiated vertical integration. Several of the proprietary hospital chains are also seeking to assemble the necessary resources through vertical integration. Humana leads the pack with its hospital PPO product, Humana Care Plus, which has over 600,000 members in at least twenty markets. American Medical International (AMI) has fielded "Amicare" as its triple choice product and is aggressively seeking to develop HMOs and PPOs to support it. For a time, Hospital Corporation of America (HCA) also pursued this strategy, having acquired four HMOs, three third-party administrators (TPAs), and New Century Life Insurance Company, but has recently shifted its approach as will be described below. Also, National Medical Enterprises (NME) embarked in 1984 on a strategy of acquiring HMOs and insurance capabilities, but has now apparently set that aside. The HCA and NME experiences, recent management shake up in AMI, and the losses Humana is now undergoing with its PPO product, raise questions about the likely future of this strategic approach for hospital chains.
(3) HMO-initiated vertical integration. The do-it-yourself approach also has adherents in the HMO industry. Among the national HMO chains, both Maxicare and United Healthcare have acquired insurance shells. Maxicare, with nineteen plans and 784,000 members, acquired Armour Life and will introduce a triple choice product this year, while United, with thirty-two plans and 822,000 members, has had great success with its so-called indemnity wraparound product. This variant of the triple choice permits the enrollee to opt out of the independent practice association (IPA) panel at point of service and to go into a deductible/ copayment structure for that service.
(4) Insurer joint ventures. A relatively new development has been the formation of joint ventures among insurers to develop HMOs and/ or PPOs. In most cases, the carriers involved are regional or second-tier companies who do not have the resources to develop a national managed care network on their own. The first of these was formed by Great West Life and seven other carriers (CNA, Crown, Mony, Guardian, Pilot, State Mutual, and Time) in collaboration with Health Data Institute. This group, marketing under the name Private Healthcare Systems, is seeking to form PPOs in up to forty markets in the next two years. The most recent announcement joins John Hancock, The Hartford, and Northwestern National Life in another joint venture to form alternative delivery systems.
(5) Insurer-provider joint ventures. Another major approach involves joint ventures among some of the insurance and hospital giants. The first of these was the Aetna-Voluntary Hospitals of America (VHA) joint venture, known as Partners National Health Plan, aimed at setting up HMOs and PPOs around member hospitals. This was quickly followed by the Occidental/ Provident joint venture with the 1,300-hospital Volun- tary Healthcare Systems chain, and most recently by the announcement of the Equitable-HCA joint venture. This last has surprised insurance competitors by the decision of the Equitable to put its entire book of medical and nonmedical group insurance business into the joint venture. This category also includes the Metropolitan which is aggressively forming HMOs on a 50-50 jointly owned basis with local provider groups.
(6) Insurer-HMO joint ventures. Finally, there are the growing series of Lincoln National joint ventures with different HMOs-U.S. Healthcare, Peak, and Pace. My guess is that we will see more of these. The picture that emerges is of three industry sectors undergoing enormously rapid change, mostly within the last two years and in a way not predicted before then. Exhibit 1 lists the ten leading commercial group insurance carriers ranked according to direct life and health premium and premium equivalents. With the exception of only one company, all of these industry giants are aggressively pursuing integrated managed care products through either vertical integration or joint ventures. Among the hospital chains, Exhibit 2 shows that all six of the leading proprietary 
Exhibit 1 Leading Group Insurance Carriers
Some Tentative Conclusions
To return to my parable and to paraphrase Charles Dickens, so much for the ghost of elephant past and elephant now, what about the ghost of elephant to come? I can foresee three important trends.
Restructuring of group insurance. First, the coming together of the health care and group insurance businesses is producing some fundamental changes for insurers. Group insurance involves quite a range of different products, running from medical benefits, to dental, long-term disability, travel accident and accidental death and dismemberment, life, and a variety of specialty products. The medical portion, though, has been by far the largest piece-typically comprising 60-80 percent of premium in a carrier's book of business-and has been the linchpin of the package sale of products to the employer. Whether you got the package usually depended mostly on your capabilities on the medical side.
Further, you usually didn't make much on the medical side-typical profit margins on medical would run under 1 percent of premium, and that's if you were successful. We estimate that a majority of group insurers have lost money in more years than not on medical insurance over the last decade. However, you would hope to do better on the other products in the package which usually produce higher margins.
So the group business is a tough, hotly competitive marketplace with medical insurance serving as the key to the very important package sale. Now, with managed care products substituting for traditional indemnity medical, insurers are having to deal with a new linchpin-and it is a potentially attractive one, since typical HMO margins exceed those on the indemnity medical side. This is why some group insurers are now willing to put some or all of their group insurance book into joint venture pots to manufacture managed care arrangements. They are doing it because they need the new linchpin, and because getting half of a higher margin product might just work out to be better than all of a low-or no-margin product whose market share is declining.
But this involves great risks for the carriers: a scary new exposure to malpractice costs and publicity, the cost of front-end capital to build an HMO or PPO network, and the special vagaries of joint ventures where you have to share in some fashion the responsibilities for account control and customer service. This suggests that what we are seeing in group insurance is more than the typical addition of a new product line. It has in it the seeds of a fundamental restructuring of the business-a marketdriven restructuring whose full implications are far from clear to all of us who are participating.
Consolidation and absorption of the HMO industry. Second, we are seeing the beginnings of a major change also in the HMO industry. This has two parts. First, as has now been said by many industry watchers, the HMO business is consolidating. InterStudy figures bear this out. Of all new plan starts in 1985; about two-thirds of these new plans were begun by the national HMO chains and only one-third by independent HMOs. There are a lot of reasons for this but it probably starts with the growing oversupply of HMOs in many markets and the intense price competition that has begun. Further, the price to play is growing as marketing, advertising, and systems costs mount. Small or single HMO plans find those costs hard to carry. And as triple choice products take hold, the competitive situation for stand-alone HMOs will get even tougher.
The other trend seems to be an absorption of the HMO business by the insurance industry. Whether through new plan starts by the vertically integrated carriers (CIGNA, Prudential), or through acquisitions (Travelers), or by joint ventures (Metropolitan, Aetna, Lincoln National), the large insurers are starting to dominate this business. And the moves toward IPAs, PPOs, experience rating, and integrated products requiring insurance licenses are all making the HMOs look and behave more like insurers. Even the national HMO chains will not be able to resist this trend. Whether they change through self-initiated adaptation, joint venture, or acquisition, the days of the HMO-only chain are probably numbered.
The battle of the Supermeds, My final conclusion is that we are indeed entering an era of emergence of the "Supermeds"-national insurance and managed care organizations that will be battling it out in the marketplace. That is not to say that local and regional HMOs and group insurers on October 10, 2017 by HW Team will not survive-the good ones will, but it will become harder and harder. The Supermeds and their large employer customers will drive the development of new products and data processing systems, and the market niches will get harder to defend.
This coming competition will use all the tools of modern advertising, public relations, national branding, customer service, and promotion. Price will be important, and HMO operators will have to learn how to manage costs better on the ambulatory side as virtually all the competitors wring the fat out of the inpatient side of the system. But ultimately what should emerge is a competitive climate in which quality becomes the basis for consumer choice. Employers and employees alike will seek quality measured in terms of access, service standards, and medical care inputs and outcomes. While we have yet to see much progress in the HMO industry on measuring and competing on the basis of quality, it is coming. And that should all be to the good for consumers.
These are exciting days for everyone involved in the health care business. Competitive forces have taken hold in a fragmented industry in ways that policy thinkers could never have predicted. A period of disruption, severe price competition, and consolidation is still ahead of us, but the direction of movement and change are positive. If the blind man could see, he would probably like the shape of the elephant that is emerging.
